Overview


According to FutureWise analysis, the market for clinical oncology next generation sequencing in 2023 is US$ 0.43 billion, and is expected to reach US$ 1.49 billion by 2031 at a CAGR of 16.70%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Clinical Oncology Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Clinical Oncology Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • Myriad Genetics, Inc.
  • Beijing Genomics Institute (BGI)
  • Qiagen NV
  • Perkin Elmer, Inc.
  • Pacific Bioscience, Inc.
  • Partek, Inc.
  • Foundation Medicine Inc.
  • Oxford Nanopore Technologies Ltd.
  • Paradigm Diagnostics, Inc
  • Caris Life Sciences
  • Eurofins Scientific S.E.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing and Resequencing

By Workflow

  • NGS Pre-Sequencing
  • NGS Sequencing
  • NGS Data Analysis

By Application

  • Screening
    • Sporadic Cancer
    • Inherited Cancer
  • Companion Diagnostics
  • Others

By End User

  • Hospitals
  • Clinics
  • Laboratories

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Clinical Oncology Next Generation Sequencing Market By Technology, By Workflow, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regionsβ€”North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
  • 2.   Research Methodology
  • 3.   Executive Summary
  • 4.   Clinical Oncology Next Generation Sequencing Market Variables, Trends and Scope
  • 5.   Market Overview
  • 6.   Clinical Oncology Next Generation Sequencing Market Analysis Tools
  • 7.   Clinical Oncology Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2024-2032 (USD Million)
  • 8.   Clinical Oncology Next Generation Sequencing Market, By Workflow Historical Analysis and Forecast 2024-2032 (USD Million)
  • 9.   Clinical Oncology Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
  • 10.   Clinical Oncology Next Generation Sequencing Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
  • 11.   North America Clinical Oncology Next Generation Sequencing Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 12.   Latin America Clinical Oncology Next Generation Sequencing Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 13.   Europe Clinical Oncology Next Generation Sequencing Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 14.   Asia Pacific Clinical Oncology Next Generation Sequencing Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 15.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 16.   Market Share Analysis and Competitive Landscape
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
  • 18.   Pre and Post COVID-19 Impact
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients